David S Egilman

Summary

Publications

  1. ncbi request reprint A proposal for a safe exposure level for diacetyl
    David S Egilman
    Never Again Consulting, Attleboro, MA, USA
    Int J Occup Environ Health 17:122-34. 2011
  2. ncbi request reprint Popcorn-worker lung caused by corporate and regulatory negligence: an avoidable tragedy
    David Egilman
    Brown University, Attleboro, MA 02703, USA
    Int J Occup Environ Health 13:85-98. 2007
  3. ncbi request reprint Handling conflicts of interest between industry and academia
    David S Egilman
    JAMA 289:3240; author reply 3240-1. 2003
  4. ncbi request reprint Exposing the "myth" of ABC, "anything but chrysotile": a critique of the Canadian asbestos mining industry and McGill University chrysotile studies
    David Egilman
    Clinical Associate Professor, Brown University, Department of Community Health, Providence, Rhode Island, USA
    Am J Ind Med 44:540-57. 2003
  5. pmc What have we learnt from Vioxx?
    Harlan M Krumholz
    Department of Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208088, New Haven, CT 06520 8088, USA
    BMJ 334:120-3. 2007
  6. ncbi request reprint MetLife and its corporate allies: dust diseases and the manipulation of science
    David S Egilman
    Department of Family Medicine, Brown University, Attleboro, MA 02703, USA
    Int J Occup Environ Health 19:287-303. 2013
  7. doi request reprint Spin your science into gold: direct to consumer marketing within social media platforms
    David Egilman
    Department of Family Medicine, Brown University, Warren Alpert School of Medicine, 8 N Main Street, Suite 401, Attleboro, MA, USA
    Work 41:4494-502. 2012
  8. ncbi request reprint Bronchiolitis obliterans and consumer exposure to butter-flavored microwave popcorn: a case series
    David S Egilman
    Department of Family Medicine, Brown University, Providence, Rhode Island, USA
    Int J Occup Environ Health 18:29-42. 2012
  9. doi request reprint A case of occupational peritoneal mesothelioma from exposure to tremolite-free chrysotile in Quebec, Canada: A black swan case
    David Egilman
    Brown University, Department of Family Medicine Health, Providence, RI, USA
    Am J Ind Med 54:153-6. 2011
  10. ncbi request reprint Fiber types, asbestos potency, and environmental causation: a peer review of published work and legal and regulatory scientific testimony
    David Egilman
    Department of Community Medicine, Brown University, USA
    Int J Occup Environ Health 15:202-28. 2009

Detail Information

Publications25

  1. ncbi request reprint A proposal for a safe exposure level for diacetyl
    David S Egilman
    Never Again Consulting, Attleboro, MA, USA
    Int J Occup Environ Health 17:122-34. 2011
    ..The levels of exposure we found to be unsafe include ranges that popcorn consumers may potentially be exposed to, indicating a risk of severe lung disease (including BO) for some consumers...
  2. ncbi request reprint Popcorn-worker lung caused by corporate and regulatory negligence: an avoidable tragedy
    David Egilman
    Brown University, Attleboro, MA 02703, USA
    Int J Occup Environ Health 13:85-98. 2007
    ....
  3. ncbi request reprint Handling conflicts of interest between industry and academia
    David S Egilman
    JAMA 289:3240; author reply 3240-1. 2003
  4. ncbi request reprint Exposing the "myth" of ABC, "anything but chrysotile": a critique of the Canadian asbestos mining industry and McGill University chrysotile studies
    David Egilman
    Clinical Associate Professor, Brown University, Department of Community Health, Providence, Rhode Island, USA
    Am J Ind Med 44:540-57. 2003
    ..Beginning in the 1930s, the Canadian asbestos industry created and advanced the idea that chrysotile asbestos is safer than asbestos of other fiber types...
  5. pmc What have we learnt from Vioxx?
    Harlan M Krumholz
    Department of Medicine, Yale University School of Medicine, 333 Cedar Street, PO Box 208088, New Haven, CT 06520 8088, USA
    BMJ 334:120-3. 2007
  6. ncbi request reprint MetLife and its corporate allies: dust diseases and the manipulation of science
    David S Egilman
    Department of Family Medicine, Brown University, Attleboro, MA 02703, USA
    Int J Occup Environ Health 19:287-303. 2013
    ..Knowledge that asbestos and silica were hazardous to health became public long after the industry knew of the health concerns. This delay was largely influenced by the interests of Metropolitan Life Insurance Company (MetLife)...
  7. doi request reprint Spin your science into gold: direct to consumer marketing within social media platforms
    David Egilman
    Department of Family Medicine, Brown University, Warren Alpert School of Medicine, 8 N Main Street, Suite 401, Attleboro, MA, USA
    Work 41:4494-502. 2012
    ..We describe some examples of the FDA's application of historic regulations to pharmaceutical company use of this new medium and suggest...
  8. ncbi request reprint Bronchiolitis obliterans and consumer exposure to butter-flavored microwave popcorn: a case series
    David S Egilman
    Department of Family Medicine, Brown University, Providence, Rhode Island, USA
    Int J Occup Environ Health 18:29-42. 2012
    ..Some manufacturers have substituted diacetyl with other alpha-diketones that are likely to pose a similar risk. Simple consumer practices such as cooling the popcorn bag would eliminate the risk of severe lung disease...
  9. doi request reprint A case of occupational peritoneal mesothelioma from exposure to tremolite-free chrysotile in Quebec, Canada: A black swan case
    David Egilman
    Brown University, Department of Family Medicine Health, Providence, RI, USA
    Am J Ind Med 54:153-6. 2011
    ..The asbestos industry and scientists it has sponsored, for example, have argued that commercial chrysotile does not cause peritoneal mesothelioma...
  10. ncbi request reprint Fiber types, asbestos potency, and environmental causation: a peer review of published work and legal and regulatory scientific testimony
    David Egilman
    Department of Community Medicine, Brown University, USA
    Int J Occup Environ Health 15:202-28. 2009
    ..and Price and Ware, and pathologic studies and testimony by Roggli and others, claim that background exposures are benign. These are fatally flawed because of methodological and analytic errors...
  11. ncbi request reprint Against anti-health epidemiology: corporate obstruction of public health via manipulation of epidemiology
    David Egilman
    Brown University, Attleboro, MA 02703, USA
    Int J Occup Environ Health 13:118-24. 2007
    ....
  12. ncbi request reprint Corporate corruption of science--the case of chromium(VI)
    David Egilman
    Int J Occup Environ Health 12:169-76. 2006
    ..This situation demonstrates the insidious and effective influence of industry on the regulatory process...
  13. ncbi request reprint Over a barrel: corporate corruption of science and its effects on workers and the environment
    David S Egilman
    Int J Occup Environ Health 11:331-7. 2005
    ..This issue offers examples of how corporations influence science, shows the effects that influence has on environmental and occupational health, and provides evidence of a systemic problem...
  14. ncbi request reprint Abuse of epidemiology: automobile manufacturers manufacture a defense to asbestos liability
    David S Egilman
    Department of Community Health, Brown University, Providence, Rhode Island, USA
    Int J Occup Environ Health 11:360-71. 2005
    ..But the absence of evidence is not evidence of the absence of an effect...
  15. ncbi request reprint The beryllium "double standard" standard
    David S Egilman
    Never Again Consulting, Attleboro, MA 02703, USA
    Int J Health Serv 33:769-812. 2003
    ....
  16. ncbi request reprint Maximizing profit and endangering health: corporate strategies to avoid litigation and regulation
    Susanna Rankin Bohme
    Int J Occup Environ Health 11:338-48. 2005
    ..Public health professionals can learn from this strategy how to effectively build scientific and public opinion that prioritizes both good science and the public health...
  17. ncbi request reprint Suppression bias at the Journal of Occupational and Environmental Medicine
    David S Egilman
    Brown University, Providence, Rhode Island, USA
    Int J Occup Environ Health 11:202-4. 2005
    ..A reputable journal has a responsibility to eschew corporate interests and work to uncover science hidden by interests that do not prioritize the pursuit of truth. JOEM needs to re-examine its priorities...
  18. pmc Study of neurontin: titrate to effect, profile of safety (STEPS) trial: a narrative account of a gabapentin seeding trial
    Samuel D Krumholz
    Never Again Consulting LLC, Providence, Rhode Island, USA
    Arch Intern Med 171:1100-7. 2011
    ..Seeding trials, clinical studies conducted by pharmaceutical companies for marketing purposes, have rarely been described in detail...
  19. ncbi request reprint Manipulated data in Shell's Benzene Historical Exposure Study
    David Egilman
    Brown University, Department of Community Health, Providence, Rhode Island, USA
    Int J Occup Environ Health 13:222-32. 2007
    ..A review of the raw data on which Shell and its consultants relied reveals that Shell manipulated and omitted data in order to reach conclusions that exculpated it from liability and helped delay stricter benzene regulation...
  20. ncbi request reprint IJOEH and the critique of bias
    David S Egilman
    Int J Occup Environ Health 14:147-51. 2008
  21. ncbi request reprint American College of Occupational and Environmental Medicine (ACOEM): a professional association in service to industry
    Joseph LaDou
    Division of Occupational and Environmental Medicine, University of California School of Medicine, San Francisco, CA 94143 0924, USA
    Int J Occup Environ Health 13:404-26. 2007
    ..This paper chronicles the history of occupational medicine and industry physicians as influenced and even controlled by corporate leaders...
  22. ncbi request reprint Differential peeky bias
    David S Egilman
    Int J Occup Environ Health 12:294. 2006
  23. ncbi request reprint The ADVANTAGE seeding trial: a review of internal documents
    Kevin P Hill
    McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
    Ann Intern Med 149:251-8. 2008
    ..Seeding trials, clinical studies conducted by pharmaceutical companies that are designed to seem as if they answer a scientific question but primarily fulfill marketing objectives, have not been described in detail...
  24. ncbi request reprint Chevron-Texaco's science
    David S Egilman
    Int J Occup Environ Health 11:456-7. 2005
  25. ncbi request reprint Avoiding the regulatory capture of the Food and Drug Administration
    David S Egilman
    Arch Intern Med 167:732-3. 2007